Anika Therapeutics | ANIK - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Abbott USD 6.8B 1.72B 2026-03
Agenus USD 35M 32M 2026-03
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Halozyme Therapeutics USD 309.75M 175.93M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Insmed USD 582.19M 71.74M 2026-03
Integra LifeSciences USD 236.81M 1.76M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
J&J USD 21.69B 1.98B 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
MacroGenics USD 66.52M 9.3M 2026-03
Merit Medical Systems USD 488.08M 41.68M 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Stryker USD 2.88B 1.13B 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Xencor USD 14.17M 39.9M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03